Caricamento...
The role of RBM10 mutations in the development, treatment, and prognosis of lung adenocarcinoma
RBM10 is the RNA-binding protein often absent or mutated in lung adenocarcinoma, rendering it as a potential biomarker or even therapeutic target to prolongate survival time. In this study, we investigated the involvement of RBM10 mutation in the pathogenesis and tumorigenesis of lung adenocarcinoma...
Salvato in:
| Pubblicato in: | Cell Cycle |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7714495/ https://ncbi.nlm.nih.gov/pubmed/33064970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384101.2020.1829801 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|